Modern Management of Anthracycline-Induced Cardiotoxicity in Lymphoma Patients: Low Occurrence of Cardiotoxicity with Comprehensive Assessment and Tailored Substitution by Nonpegylated Liposomal Doxorubicin.
about
Modern Management of Anthracycline-Induced Cardiotoxicity in Lymphoma Patients: Low Occurrence of Cardiotoxicity with Comprehensive Assessment and Tailored Substitution by Nonpegylated Liposomal Doxorubicin.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Modern Management of Anthracyc ...... gylated Liposomal Doxorubicin.
@en
Modern Management of Anthracyc ...... gylated Liposomal Doxorubicin.
@nl
type
label
Modern Management of Anthracyc ...... gylated Liposomal Doxorubicin.
@en
Modern Management of Anthracyc ...... gylated Liposomal Doxorubicin.
@nl
prefLabel
Modern Management of Anthracyc ...... gylated Liposomal Doxorubicin.
@en
Modern Management of Anthracyc ...... gylated Liposomal Doxorubicin.
@nl
P2093
P2860
P1433
P1476
Modern Management of Anthracyc ...... gylated Liposomal Doxorubicin.
@en
P2093
Attilio Olivieri
Caterina Bocci
Claudia Montevecchi
Gian Piero Perna
Guido Gini
Jacopo Olivieri
Pietro Leoni
P2860
P304
P356
10.1634/THEONCOLOGIST.2016-0289
P577
2017-03-08T00:00:00Z